Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy

@inproceedings{Ahmet2011AdrenalSA,
  title={Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy},
  author={Alexandra H Ahmet and Harold L. Kim and Sheldon Spier},
  booktitle={Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology},
  year={2011}
}
Inhaled corticosteroids (ICSs) are the most effective anti-inflammatory agents available for the treatment of asthma and represent the mainstay of therapy for most patients with the disease. Although these medications are considered safe at low-to-moderate doses, safety concerns with prolonged use of high ICS doses remain; among these concerns is the risk of adrenal suppression (AS). AS is a condition characterized by the inability to produce adequate amounts of the glucocorticoid, cortisol… CONTINUE READING